Download PDF
Thromb Haemost 2002; 88(04): 688-689
DOI: 10.1055/s-0037-1613278
Letters to the Editor
Schattauer GmbH

High Plasma Levels of Lipoprotein(a) in Uremic Patients are Related to Markers of Inflammation, and to Activated, not Impaired, Fibrinolysis

Antonio Gatica
1   Departments of Hematology and Nephrology, School of Medicine, P Catholic University of Chile
,
Olga Panes
1   Departments of Hematology and Nephrology, School of Medicine, P Catholic University of Chile
,
Rodrigo Tagle
1   Departments of Hematology and Nephrology, School of Medicine, P Catholic University of Chile
,
Jaime Pereira
1   Departments of Hematology and Nephrology, School of Medicine, P Catholic University of Chile
,
Diego Mezzano
1   Departments of Hematology and Nephrology, School of Medicine, P Catholic University of Chile
› Author Affiliations
Further Information

Publication History

Received 14 March 2002

Accepted 21 May 2002

Publication Date:
09 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Dahlen GH, Stenlund H. Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance. Clin Genet 1997; 52: 272-80.
    PubMedGoogle Scholar
  • 2 Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal disease. Am J Kidney Dis 1996; 27: 1-25.
    CrossrefPubMedGoogle Scholar
  • 3 Hajjar K, Gavish D, Breslow J, Nachman R. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303-5.
    CrossrefPubMedGoogle Scholar
  • 4 Grainger D, Kirschenlohr H, Metcalfe J, Wiessberg P, Wade D, Lawn R. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 1993; 260: 1655-8.
    CrossrefPubMedGoogle Scholar
  • 5 Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM, Broze Jr GJ, Simari RD. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood 2001; 98: 2980-7.
    CrossrefPubMedGoogle Scholar
  • 6 Ledue TB, Neveux LM, Palomaki GE, Ritchie RF, Craig WY. The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response. Clin Chim Acta 1993; 223: 73-82.
    CrossrefPubMedGoogle Scholar
  • 7 Noma A, Abe A, Maeda S, Seishima M, Makino K, Yano Y, Shimokawa K. Lp(a): an acute-phase reactant?. Chem Phys Lipids 1994; 67-68: 411-7.
    CrossrefPubMedGoogle Scholar
  • 8 Mezzano D, Tagle R, Panes O, Perez M, Downey P, Muñoz B, Aranda E, Barja P, Thambo S, González F, Mezzano S, Pereira J. Hemostatic disorder in uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis. Thromb Haemost 1996; 76: 312-21.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Mezzano D, Pais EO, Aranda E, Panes O, Downey P, Ortiz M, Tagle R, González F, Quiroga T, Cáceres MS, Leighton F, Pereira J. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endotelial dysfunction in uremia. Kidney Int 2001; 60: 1844-50.
    CrossrefPubMedGoogle Scholar
  • 10 Kario K, Matsuo T, Kobayashi H, Matsuo M, Asada R, Koide M. High lipoprotein(a) levels in chronic hemodialysis patients are closely related to the acute phase reaction. Thromb Haemost 1995; 74: 1020-4.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Hervio L, Girard-Globa A, Durlach V, Angles-Cano E. The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin. Eur J Clin Invest 1996; 26: 411-7.
    CrossrefPubMedGoogle Scholar
  • 12 Falco C, Estelles A, Dalmau J, Espana F, Aznar J. Influence of lipoprotein(a) levels and isoforms on fibrinolytic activity: study in families with high lipoprotein(a) levels. Thromb Haemost 1998; 79: 818-23.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Halvorsen S, Skjonsberg OH, Berg K, Ruyter R, Godal HC. Does Lp(a) lipoprotein inhibit the fibrinolytic system?. Thromb Res 1992; 68: 223-32.
    CrossrefPubMedGoogle Scholar
  • 14 Lu H, Bruckert J, Soria J, Li H, de Gennes JL, Legrand A, Peynet J, Soria C. Absence of inhibition by lipoprotein(a) inhibition of tPA induced thrombolysis in a patient’s plasma milieu. Blood Coagul Fibrinolysis 1990; 01: 513-6.
    PubMedGoogle Scholar
  • 15 Mao SJ, Tucci MA. Lipoprotein(a) enhances plasma clot lysis in vitro. FEBS Lett 1990; 267: 131-4.
    CrossrefPubMedGoogle Scholar
  • 16 Liu JN, Harpel PC, Pannell R, Gurevich V. Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator. Biochemistry 1993; 32: 9694-700.
    CrossrefPubMedGoogle Scholar